Abstract |
In previous studies it has been demonstrated that the plant alkaloid voacamine (1), used at noncytotoxic concentrations, enhanced the cytotoxicity of doxorubicin and exerted a chemosensitizing effect on cultured multidrug-resistant (MDR) U-2 OS-DX osteosarcoma cells. The in vitro investigations reported herein gave the following results: (i) the chemosensitizing effect of 1, in terms of drug accumulation and cell survival, was confirmed using SAOS-2-DX cells, another MDR osteosarcoma cell line; (ii) compound 1 enhanced the cytotoxic effect of doxorubicin also on the melanoma cell line Me30966, intrinsically drug resistant and P-glycoprotein-negative; (iii) at the concentrations used to sensitize tumor cells, 1 was not cytotoxic to normal cells (human fibroblasts). These findings suggest possible applications of voacamine (1) in integrative oncologic therapies against resistant tumors.
|
Authors | Maria Condello, Dario Cosentino, Silvia Corinti, Gabriella Di Felice, Giuseppina Multari, Francesca Romana Gallo, Giuseppe Arancia, Stefania Meschini |
Journal | Journal of natural products
(J Nat Prod)
Vol. 77
Issue 4
Pg. 855-62
(Apr 25 2014)
ISSN: 1520-6025 [Electronic] United States |
PMID | 24720452
(Publication Type: Journal Article)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B
- Alkaloids
- voacamine
- Ibogaine
- Doxorubicin
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B
(metabolism)
- Alkaloids
(chemistry, pharmacology)
- Apoptosis
(drug effects)
- Bone Neoplasms
(drug therapy)
- Cell Survival
(drug effects)
- Doxorubicin
(pharmacology)
- Drug Resistance, Multiple
(drug effects)
- Drug Resistance, Neoplasm
(drug effects)
- Fibroblasts
(metabolism)
- Fluorescent Antibody Technique
- Humans
- Ibogaine
(analogs & derivatives, chemistry, pharmacology)
- Melanoma
(drug therapy)
- Molecular Structure
- Osteosarcoma
(drug therapy)
|